Literature DB >> 15060116

Assessment of association between variants and haplotypes of the remaining TBX1 gene and manifestations of congenital heart defects in 22q11.2 deletion patients.

A Rauch, K Devriendt, A Koch, R Rauch, M Gewillig, C Kraus, M Weyand, H Singer, A Reis, M Hofbeck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060116      PMCID: PMC1735727          DOI: 10.1136/jmg.2003.010975

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  12 in total

1.  Investigation of the 22q11.2 candidate region in patients with midline facial defects with hypertelorism.

Authors:  M Simioni; E Lopes Freitas; T Paiva Vieira; I Lopes-Cendes; V Lúcia Gil-da-Silva-Lopes
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

2.  Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions.

Authors:  Christiane Zweier; Heinrich Sticht; Inci Aydin-Yaylagül; Christine E Campbell; Anita Rauch
Journal:  Am J Hum Genet       Date:  2007-01-18       Impact factor: 11.025

Review 3.  Transcription factor pathways and congenital heart disease.

Authors:  David J McCulley; Brian L Black
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

Review 4.  Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome.

Authors:  Nicole Philip; Anne Bassett
Journal:  Behav Genet       Date:  2011-05-15       Impact factor: 2.805

5.  Investigation of TBX1 gene deletion in Iranian children with 22q11.2 deletion syndrome: correlation with conotruncal heart defects.

Authors:  Hamid Ganji; Mansoor Salehi; Maryam Sedghi; Hossein Abdali; Nayereh Nouri; Leyli Sadri; Majid Hosseinzadeh; Bahareh Vakili; Mahdi Lotfi
Journal:  Heart Asia       Date:  2013-09-12

6.  Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.

Authors:  Tingwei Guo; Donna McDonald-McGinn; Anna Blonska; Alan Shanske; Anne S Bassett; Eva Chow; Mark Bowser; Molly Sheridan; Frits Beemer; Koen Devriendt; Ann Swillen; Jeroen Breckpot; Maria C Digilio; Bruno Marino; Bruno Dallapiccola; Courtney Carpenter; Xin Zheng; Jacob Johnson; Jonathan Chung; Anne Marie Higgins; Nicole Philip; Tony J Simon; Karlene Coleman; Damian Heine-Suner; Jordi Rosell; Wendy Kates; Marcella Devoto; Elizabeth Goldmuntz; Elaine Zackai; Tao Wang; Robert Shprintzen; Beverly Emanuel; Bernice Morrow
Journal:  Hum Mutat       Date:  2011-09-16       Impact factor: 4.878

7.  Overt cleft palate phenotype and TBX1 genotype correlations in velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.

Authors:  Sean B Herman; Tingwei Guo; Donna M McDonald McGinn; Anna Blonska; Alan L Shanske; Anne S Bassett; Eva W C Chow; Mark Bowser; Molly Sheridan; Frits Beemer; Koen Devriendt; Ann Swillen; Jeroen Breckpot; M Cristina Digilio; Bruno Marino; Bruno Dallapiccola; Courtney Carpenter; Xin Zheng; Jacob Johnson; Jonathan Chung; Anne Marie Higgins; Nicole Philip; Tony Simon; Karlene Coleman; Damian Heine-Suner; Jordi Rosell; Wendy Kates; Marcella Devoto; Elaine Zackai; Tao Wang; Robert Shprintzen; Beverly S Emanuel; Bernice E Morrow
Journal:  Am J Med Genet A       Date:  2012-10-03       Impact factor: 2.802

Review 8.  22q11 deletion syndrome: a role for TBX1 in pharyngeal and cardiovascular development.

Authors:  Peter J Scambler
Journal:  Pediatr Cardiol       Date:  2010-04       Impact factor: 1.655

9.  Single nucleotide polymorphism discovery in TBX1 in individuals with and without 22q11.2 deletion syndrome.

Authors:  Carrie L Heike; Jacqueline R Starr; Mark J Rieder; Michael L Cunningham; Karen L Edwards; Ian B Stanaway; Dana C Crawford
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-01

Review 10.  When half is not enough: gene expression and dosage in the 22q11 deletion syndrome.

Authors:  D W Meechan; T M Maynard; D Gopalakrishna; Y Wu; A S LaMantia
Journal:  Gene Expr       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.